Search

everythinglearnresearchcommunity

for

Search:↓

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Finasteride is a safe and effective long-term treatment for male hair loss, especially when started early.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

The pandemic worsened physical and mental challenges for women with PCOS.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

The pandemic changed how often certain skin conditions were diagnosed.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

The cuticle significantly contributes to hair stiffness, making up about 60% of the total bending stress.

A woman's hair mostly regrew after hair loss from the COVID-19 vaccine with treatment.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Long COVID symptoms vary and are influenced by personal and health factors.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Age, gender, obesity, and smoking increase the risk of severe COVID-19.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

The pandemic increased stress-related skin conditions and those affected by behavior changes.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

Resident doctors had more facial skin discoloration than medical students during COVID-19.

Mothers with lower stress during pregnancy but higher stress after birth had infants with lower development scores.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The extract from the plant Adiantum capillus-veneris might be used to treat COVID-19.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.